VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $17,512,000 | -22.0% | 1,100,000 | +1.9% | 0.00% | -20.0% |
| Q4 2017 | $22,442,000 | +2.9% | 1,080,000 | +548.6% | 0.01% | -16.7% |
| Q3 2014 | $21,817,000 | +36.4% | 166,500 | +31.6% | 0.01% | +50.0% |
| Q2 2014 | $15,997,000 | +5.7% | 126,500 | +10.0% | 0.00% | 0.0% |
| Q1 2014 | $15,129,000 | +12.1% | 115,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $13,491,000 | +12.5% | 115,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $11,991,000 | – | 115,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
| GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
| MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
| GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
| AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
| HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
| NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
| Twin Tree Management, LP | 455 | $27,000 | 0.00% |